Clinical Trials
Rare Disease Patient Platform Raremark Partners With TriNetX
TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), announced that Raremark, a...
News
Recipharm names 2019 International Environmental Award winner
Recipharm has announced its 2019 International Environmental Award will be presented to Dana Kolpin, Research Hydrologist at the U.S. Geological Survey Central Midwest Water...
Press Releases
Signant Health invests for growth with the opening of its new Philadelphia-area office
Signant Health, an industry-leading clinical research technology and solutions company, is proud to announce that it has officially opened a new, leading edge office...
News
CPhI Japan to be postponed on request of event attendees
CPhI Japan – organised by Informa Markets – announces that the event will be postponed until a new date later in the year after...
Press Releases
Sun Pharma Launches RIOMET ER Oral Suspension in the U.S.
Sun Pharmaceutical Industries Ltd. announced that one of its whollyowned subsidiaries has launched Riomet ER™ in the U.S. as an adjunct to diet and...
Articles
Trademarks in the medical sphere: Practice, examination and obstacles for registration in Russia, Ukraine and the CIS
Pharmaceutical industry in Russia, Ukraine and in other CIS countries can be considered one of the most complex industries with a view to the...
Press Releases
Dulaglutide Receives FDA Approval for Reducing MACE in Type 2 Diabetics
The U.S. FDA has approved Trulicity® (dulaglutide) for the reduction of major adverse cardiovascular events (MACE) in adults with type 2 diabetes who have...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read